Germany – Pharmaceuticals – Open House Biologic Discount Contracts 2025-19 - Adalimumab
Deutschland – Arzneimittel – Open-House-Biologika-Rabattverträge 2025-19 - Adalimumab
Germany · Hamburg
What the buyer is looking for
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Adalimumab im Rahmen eines Open-House-Verfahrens.
Description as published (DE).
Contract
BuyerTechniker Krankenkasse
TypeSupplies
Estimated valuevalue not published
Published13 June 2025
CategoryMedical equipment & pharma · CPV 33600000
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Computacenter AG & Co. oHG | 76 | 2006–2026 |
| Siehe im Feld "Allgemeine Informationen" | 55 | 2023–2026 |
| Hexal AG · Holzkirchen | 43 | 2011–2026 |
| Aliud Pharma GmbH · Laichingen | 38 | 2011–2025 |
| Aristo Pharma GmbH · Berlin | 33 | 2012–2026 |
From 13.7M documented awards · regular winners know this buyer's requirements — that is your competition.
How often this buyer tenders this
201986
202036
202122
202229
202354
2024263
20251
2025550
2026275
Who knows the rhythm prepares instead of reacting.
345
days until the deadline — Saturday 31 July at 00:00
How to bid
Read the full notice — Original + documents
Goes directly to this tender on TED — Tenders Electronic Daily. The full specification and all annexes are there.
Tenders like this, every morning at 7:30 in your inbox.
Start free →